Vaping: What Health Professionals Should Know Kate Feuling Porter, - - PowerPoint PPT Presentation

vaping what health professionals should know
SMART_READER_LITE
LIVE PREVIEW

Vaping: What Health Professionals Should Know Kate Feuling Porter, - - PowerPoint PPT Presentation

Vaping: What Health Professionals Should Know Kate Feuling Porter, MPH Program Manager Twin Cities Medical Society Objectives Discuss policy Describe Describe Identify & community strategies for vaping trends health risks based


slide-1
SLIDE 1

Vaping: What Health Professionals Should Know

Kate Feuling Porter, MPH Program Manager Twin Cities Medical Society

slide-2
SLIDE 2
slide-3
SLIDE 3

Objectives

Describe vaping trends in adults and adolescents Identify health risks associated with vaping Describe strategies for discussing vaping with patients Discuss policy & community based strategies to address vaping

slide-4
SLIDE 4

What do you hear people say about vaping?

slide-5
SLIDE 5

E-cigarette Trends

slide-6
SLIDE 6

E-cigarette Use by Age

Minnesota Department of Health

6% 22% 26%

Adults Young Adults (18-24) 11th Graders

slide-7
SLIDE 7

MN Adult Vapers in 2014

2014 MN Adult Tobacco Survey

12%

Never Smoker

22%

Former Smoker

66%

Current Smoker

slide-8
SLIDE 8

MN Adult Vapers in 2018

44%

Never Smoker

19%

Former Smoker

37%

Current Smoker

2018 MN Adult Tobacco Survey

slide-9
SLIDE 9

Dual Use: Cigarettes

60% of high school vapers use both

E-cigarettes Conventional Tobacco

Minnesota Student Survey, 2016

slide-10
SLIDE 10

Dual Use: Marijuana

35% of high school vapers also vaporize cannabis

E-cigarettes Marijuana

Minnesota Youth Tobacco Survey, 2017

slide-11
SLIDE 11

New Tobacco Users

slide-12
SLIDE 12

Health Risks of Nicotine

slide-13
SLIDE 13

Nicotine Addiction

slide-14
SLIDE 14

Minnesota Department of Health

Highly addictive Harms brain development during adolescence Harmful to fetal health during pregnancy

slide-15
SLIDE 15

The Rise of Vaping

slide-16
SLIDE 16

How E-cigarettes Work

Heating element

(atomizer)

Battery

rechargeable or disposable

Chamber for liquid nicotine

(tank)

Mouthpiece Optional Button

slide-17
SLIDE 17

E-liquids & Flavors

Propylene glycol + Vegetable glycerin + Flavoring chemicals + Nicotine

(extracted from tobacco)

slide-18
SLIDE 18

The Problem with Flavors

slide-19
SLIDE 19

Then and Now

JUUL Vape

slide-20
SLIDE 20

How much nicotine is in one JUUL pod?

slide-21
SLIDE 21

JUUL: A New Kind of Nicotine

slide-22
SLIDE 22

Nicotine Poisoning / Sickness

60% of high school vapers use both

In large amounts, nicotine is a poison that can cause vomiting, nausea and rapid breathing In 2014 an eighteen month old child died after accidentally drinking e-liquid

Minnesota Department of Health , 2015.

slide-23
SLIDE 23

JUUL: Now & Then

2019 2015

slide-24
SLIDE 24

JUUL Teams up with Big Tobacco

slide-25
SLIDE 25

FDA Regulations

slide-26
SLIDE 26

FDA Regulations

slide-27
SLIDE 27

Health Risks

  • f Vaping:

What We Know

slide-28
SLIDE 28

There are Still Many Unknowns

  • The harms of

cigarettes have a long latency period

  • E-cigarettes are

very new

  • Huge amount of

variation in e- cigarette devices and liquid

slide-29
SLIDE 29

EVALI

E-cigarette or vaping product use-associated lung injury

slide-30
SLIDE 30

From the CDC: Symptoms & Recommendations

Symptoms include:

  • Gastrointestinal, respiratory, and non-specific constitutional

symptoms

  • Can develop over a period of days or over several weeks

Recommendations:

  • Ask all patients with symptoms about vaping in a non-judgemental

way

  • Close follow up within 24-48 for outpatient cases
  • Corticosteroids may be helpful
  • Influenza testing should be strongly considered
  • Provide cessation / addiction services

CDC

slide-31
SLIDE 31

Early Evidence: Respiratory Health

  • Increased chronic respiratory illnesses
  • Hampers mucus clearance from airways
  • More frequent and severe asthma exacerbations
  • Aldehydes exposure → acute lung injury, lung disease,

and cancer

  • Vapor disables key protective cells in the lungs and

boosts the production of inflammatory chemicals

Scott et al., 2018, Chung et al, 2019, NASEM, 2018, McConnell, 2017,

slide-32
SLIDE 32

Early Evidence: Cardiovascular Health

  • Vapor decreases the production of nitric oxide, which

contributes to heart and blood vessel damage

  • Vaping impairs endothelial function, which often

precedes cardiovascular diseases

  • Single use of nicotine-free vape reduced blood flow

American Heart Association, 2018, Lee et al., 2019, Caporale et al, 2019

slide-33
SLIDE 33

Early Evidence: Carcinogens & Other Harmful Chemicals

  • E-cigarettes deliver many of the same

cancer-causing chemicals that are in cigarettes

  • Heavy Metals (lead, chromium, nickel) → lung, liver, heart and

brain damage

  • New case study of hard-metal pneumoconiosis
  • Volatile organic compounds → carcinogen
  • NNN → oral + esophageal carcinogen

Rubinstein, 2018; Salamanca, 2018; Bustamante, 2018, Olmedo et al., 2018

slide-34
SLIDE 34

But “nicotine-free” vapes are safe, right?

slide-35
SLIDE 35

Vaping, Cessation and the Clinic

slide-36
SLIDE 36

Vaping & Tobacco Cessation

  • E-cigarettes are not

approved by the FDA as a cessation device

  • Mixed research on the

efficacy of vaping for

cessation

  • Vaping may interfere

with quitting all nicotine

NASEM

slide-37
SLIDE 37

If Your Patients Vape

  • Educate clients on health

impacts so they can make an informed decision

  • Monitor nicotine intake and

work toward completely quitting nicotine

  • Work toward completely

quitting vaping, regardless

  • f nicotine
slide-38
SLIDE 38

Asking the Right Questions

Ask specifically about vaping, in language your patients understand

Do you JUUL? Do you vape?

slide-39
SLIDE 39

Assist

Counseling + Nicotine Replacement Therapy / Medications = Success

slide-40
SLIDE 40

FDA Approved Medications

Nicotine Gum Nicotine lozenge Nicotine patch Nicotine nasal spray Nicotine inhaler Bupropion

(Wellbutrin)

tablets Varenicline (Chantix) tablets Combination Therapy Examples:

  • Nicotine patch in

combination with short acting NRT

  • Nicotine patch in

combination with bupropion

  • Varenicline in

combination with short acting NRT

slide-41
SLIDE 41

Tobacco Treatment Resources

Free quit help for all Minnesotans, including phone counseling, email program and nicotine replacement therapy www.quitplan.com

slide-42
SLIDE 42

Youth and Young Adult Tobacco Treatment

Free texting program and peer support specifically for teens & young adult vapers www.thisisquitting.com

slide-43
SLIDE 43

Policies that Protect Kids

slide-44
SLIDE 44

Take Action

slide-45
SLIDE 45

Questions?